MIRIAM MADRY, OD
Low Vision Rehabilitation Optometrist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
MIRIAM MADRY, OD reported a CMS MIPS final score of 89.2198/100 — above the 83.1 national average — and filed 2,328 Medicare Part D claims in 2023.
- 89.2198/100
- MIPS score · +6 vs avg
- 2K
- Part D claims, 2023
- 32%
- generic prescribing
- $776.07
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
MIRIAM MADRY, OD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
89 Top 42% higher than 58% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about MIRIAM MADRY, OD?
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New York
How Low Vision Rehabilitation Optometrist compares to other specialties among New York providers
Low Vision Rehabilitation Optometrist share within New York
Low Vision Rehabilitation Optometrist is one of the more visible NUCC categories in New York
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MIRIAM MADRY, OD's 2023 MIPS final score plotted against the Low Vision Rehabilitation Optometrist national average
- MIPS Final Score
- 89.2198/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Low Vision Rehabilitation Optometrist) — 89.2198/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Low Vision Rehabilitation Optometrist US NPIs
89.2198/100 MIPS final score — 6.1 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Low Vision Rehabilitation Optometrist. Quality dim: 94.036.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MIRIAM MADRY, OD appears in the CMS NPPES registry as a Low Vision Rehabilitation Optometrist provider holding OD credentials at 147 W 142ND ST FL 1, NEW YORK, NY, 10030, with a listed phone of (212) 439-9600. NPI 1477046522 was issued on 06/13/2018. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MADRY most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,328 prescription claims written by this provider, covering 374 Medicare beneficiaries and totaling roughly $963K in drug spend, split 68% brand-name and 32% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.2198/100 for the 2023 performance year (Quality 94.036), compared with the national average of 83.1.
Low Vision Rehabilitation Optometrist is a narrow specialty nationwide, with 299 enrolled providers across 39 states and an average of 296 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1477046522 |
|---|---|
| Specialty | Low Vision Rehabilitation Optometrist |
| Credentials | OD |
| Gender | Female |
| NPI Issued | 06/13/2018 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MIRIAM MADRY, OD's current license status, disciplinary history, and board certifications with the New York State Education Department, Office of the Professions in New York before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where MIRIAM MADRY, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MIRIAM MADRY, OD. Source: openpaymentsdata.cms.gov.
Total received
$776
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — New York NYSBPMC 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to MIRIAM MADRY, OD. To verify MIRIAM MADRY, OD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
68% brand-name claims vs 32% generic, on 2,328 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 3,698
- Total Day Supply
- 107,316
- Brand vs Generic
- 68% brand / 32% generic
- Brand Drug Cost
- $939K
- Generic Drug Cost
- $25K
Patient Demographics
- Average Patient Age
- 75.4 years
- Avg HCC Risk Score
- 1.54
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 24, 65-74: 159, 75-84: 141, 85+: 50
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What MIRIAM MADRY, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
417 claims
- Restasis
Restasis
328 claims
- Lumigan
Lumigan
174 claims
- Vyzulta
Vyzulta
174 claims
- Xiidra 162
Xiidra
162 claims
- Dorzolamide-Timolol 155
Dorzolamide-Timolol
155 claims
- Combigan 123
Combigan
123 claims
- Cequa 122
Cequa
122 claims
| Drug | Claims |
|---|---|
| Latanoprost | 417 |
| Restasis Cyclosporine | 328 |
| Lumigan Bimatoprost | 174 |
| Vyzulta Latanoprostene Bunod | 174 |
| Xiidra Lifitegrast | 162 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 155 |
| Combigan Brimonidine Tartrate/Timolol | 123 |
| Cequa Cyclosporine | 122 |
| Rhopressa Netarsudil Mesylate | 89 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 84 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Low Vision Rehabilitation Optometrist Overview
How MIRIAM MADRY, OD fits within the Low Vision Rehabilitation Optometrist landscape nationally.
MIRIAM MADRY, OD's 2,328 claims are above the specialty average of 296.
Nearby Low Vision Rehabilitation Optometrist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as MADRY.
Compare Low Vision Rehabilitation Optometrist nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New York
Frequently Asked Questions
What is MIRIAM MADRY, OD's specialty? ▼
How much does MIRIAM MADRY, OD prescribe under Medicare Part D? ▼
What is MIRIAM MADRY, OD's Medicare quality score? ▼
Where is MIRIAM MADRY, OD located? ▼
What is MIRIAM MADRY, OD's NPI number? ▼
Does MIRIAM MADRY, OD prescribe more brand-name or generic drugs? ▼
How many Low Vision Rehabilitation Optometrist providers are there in the US? ▼
What drugs does MIRIAM MADRY, OD prescribe most often? ▼
Does MIRIAM MADRY, OD accept Medicare? ▼
How can I verify MIRIAM MADRY, OD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology